Last reviewed · How we verify
NCT06706830
The Role of Lung and Diaphragm Ultrasonography in Predicting Clinical Progression in Hypoxemic Respiratory Failure
trial in Diaphragm Ultrasonography in 91 participants. Completed in 23 August 2024.
1 May 2024
Quick facts
| Lead sponsor | Simge Evren |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 91 |
| Start date | 1 January 2024 |
| Primary completion | 1 May 2024 |
| Estimated completion | 23 August 2024 |
| Sites | 2 locations across Turkey (Türkiye) |
Conditions studied
- Diaphragm Ultrasonography — all drugs for Diaphragm Ultrasonography →
- Lung Ultrasound — all drugs for Lung Ultrasound →
- Hypoxemic Respiratory Failure — all drugs for Hypoxemic Respiratory Failure →
Sponsor
Simge Evren
Who can join
18 and older, any sex, with Diaphragm Ultrasonography or Lung Ultrasound. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to evaluate whether the risk of intubation in patients with hypoxemic respiratory failure who were monitored in the intensive care unit and received non-invasive mechanical ventilation and high-flow nasal oxygen treatment could be predicted using lung and diaphragm ultrasound. The main question it aims to answer is: Can lung and diaphragm ultrasound predict the risk of intubation in patients with hypoxemic respiratory failure?
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06706830
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diaphragm Ultrasonography
Currently open trials in the same condition.
- NCT07447804 — Diaphragm Morphology and Respiratory Muscle Strength in Subacute Hemiplegic Patients · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06706830 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Simge Evren
- Last refreshed: 27 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06706830.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing